Facebook tracking pixel
C43.9
ICD-10-CM
Melanoma

Find comprehensive information on melanoma diagnosis, including clinical documentation, ICD-10 CM codes (C43.x), SNOMED CT concepts, and healthcare guidelines. Learn about melanoma staging, histopathology, differential diagnosis, and treatment options. This resource provides essential information for physicians, clinicians, medical coders, and healthcare professionals involved in the diagnosis and management of melanoma skin cancer.

Also known as

Malignant Melanoma
Skin Cancer - Melanoma

Diagnosis Snapshot

Key Facts
  • Definition : Most serious skin cancer, developing from melanocytes.
  • Clinical Signs : Changing mole (asymmetry, border, color, diameter, evolving), new growth, itching, bleeding.
  • Common Settings : Dermatology clinic, primary care physician, skin cancer centers, surgical oncology.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC C43.9 Coding
C43.0-C43.9

Malignant melanoma of skin

Cancerous growth of melanocytes in the skin.

C44.0-C44.9

Other malignant neoplasms of skin

Cancers of the skin excluding melanoma and Merkel cell carcinoma.

C79.89

Secondary malignant neoplasm skin NOS

Melanoma that has spread to the skin from another primary site.

Z85.820

Personal history of malignant melanoma of skin

Patient has a documented history of skin melanoma, now resolved.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the melanoma in situ?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Malignant skin cancer from melanocytes.
Atypical mole, potential precursor to melanoma.
Benign pigmented skin lesion, not melanoma.

Documentation Best Practices

Documentation Checklist
  • Melanoma diagnosis documentation: site, size, morphology
  • ICD-10 C43, C44 coding: document primary/secondary
  • Melanoma staging: TNM, Clark level, Breslow depth
  • Lesion characteristics: ulceration, bleeding, regression
  • Diagnostic method: biopsy, excision, dermoscopy image

Coding and Audit Risks

Common Risks
  • Site UnSpecificity

    Missing or unspecified laterality (right/left) or specific site details for melanoma diagnosis impacts accurate coding and reimbursement.

  • Histology Miscoding

    Incorrect coding of melanoma histology (e.g., in situ, invasive) leads to inaccurate staging and treatment planning, impacting quality metrics.

  • Ulceration Oversight

    Failure to document ulceration status (present/absent) affects staging, prognosis, and appropriate treatment coding for melanoma.

Mitigation Tips

Best Practices
  • Thorough skin exams:ICD-10 C43.9, C44.9. Document changes, size, color.
  • Dermoscopy aids early detection: ICD-10 L87.2. Code each lesion separately.
  • Biopsy suspicious lesions: ICD-10 L76.2. Precise site, size in cm documented.
  • Photography for tracking changes: ICD-10 Z01.818. Date/time all images.
  • Multidisciplinary review for complex cases: ICD-10 Z51.81. Record consensus diagnosis.

Clinical Decision Support

Checklist
  • Verify lesion size, site, morphology (ICD-10 C43.x)
  • Confirm histopathology report: melanoma subtype (SNOMED CT)
  • Check Breslow depth, ulceration, mitoses for staging (TNM)
  • Review sentinel lymph node biopsy results if indicated
  • Assess for distant metastasis: imaging, LDH (patient safety)

Reimbursement and Quality Metrics

Impact Summary
  • Melanoma reimbursement hinges on accurate ICD-10-CM (C43.-) coding, precise staging (TNM), and microscopically confirmed diagnosis. Impacts: Improved Case Mix Index (CMI), optimized revenue.
  • Quality metrics for melanoma focus on timely diagnosis, appropriate treatment (surgery, radiation, immunotherapy), and patient follow-up. Impacts: Enhanced hospital reputation, better patient outcomes.
  • Melanoma coding errors (e.g., unspecified vs. specific histology) can lead to claim denials, reduced reimbursement, and reporting inaccuracies. Impacts: Lower hospital profitability, potential compliance issues.
  • Accurate melanoma documentation specifying site, size, and ulceration is crucial for proper staging and optimal reimbursement. Impacts: Higher severity of illness (SOI) scores, justified resource utilization.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Quick Tips

Practical Coding Tips
  • Code C43 for malignant melanoma
  • Document Breslow depth & ulceration
  • Specify site, laterality & histology
  • Use SNOMED CT for melanoma staging
  • Check ICD-10-CM guidelines for melanoma

Documentation Templates

Patient presents with a concerning skin lesion suspicious for melanoma.  History includes new or changing mole, exhibiting features concerning for malignancy such as asymmetry, border irregularity, color variegation, diameter greater than 6mm, and evolution over time (ABCDE criteria).  The patient reports  (insert pertinent negatives or positives such as itching, bleeding, pain, or no symptoms).  Family history is positive/negative for melanoma and other skin cancers.  Past medical history includes (list relevant medical conditions, sun exposure history, prior skin biopsies or melanoma diagnoses).  Physical examination reveals a (color) pigmented lesion located on the (body location), measuring (size) mm in diameter.  The lesion exhibits (describe characteristics such as asymmetry, border irregularity, color variations, elevation, ulceration).  Differential diagnosis includes melanoma, atypical nevus, basal cell carcinoma, squamous cell carcinoma, seborrheic keratosis.  Impression is suspicious for cutaneous melanoma.  Plan includes excisional biopsy with margins for histopathologic evaluation, sentinel lymph node biopsy if indicated by Breslow thickness, and referral to dermatology andor oncology for further management based on pathology results.  Patient education provided on melanoma risk factors, sun protection strategies, and skin self-examination.  ICD-10 code C43.9 Malignant melanoma of skin, unspecified will be used pending pathology confirmation.  CPT codes for the planned procedures will be determined based on the complexity of the biopsy and any additional procedures performed.  Follow-up appointment scheduled for (date) to discuss pathology results and treatment plan.